Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy

<div>Boxplot for day 30 and day 100 chimerism for each of the 3 conditioning regimens. Bu, busulfan; Cy, cyclophosphamide; Flu, fludarabine; PK, pharmacokinetics; SCT, stem cell transplant.</div>

Advances in Hematology

fig1

Figure 1

Figure 1: Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy 